203 related articles for article (PubMed ID: 27184924)
41. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes.
García-Prieto J; García-Ruiz JM; Sanz-Rosa D; Pun A; García-Alvarez A; Davidson SM; Fernández-Friera L; Nuno-Ayala M; Fernández-Jiménez R; Bernal JA; Izquierdo-Garcia JL; Jimenez-Borreguero J; Pizarro G; Ruiz-Cabello J; Macaya C; Fuster V; Yellon DM; Ibanez B
Basic Res Cardiol; 2014 Jul; 109(4):422. PubMed ID: 24951958
[TBL] [Abstract][Full Text] [Related]
42. Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models.
Tokutome M; Matoba T; Nakano Y; Okahara A; Fujiwara M; Koga JI; Nakano K; Tsutsui H; Egashira K
Cardiovasc Res; 2019 Feb; 115(2):419-431. PubMed ID: 30084995
[TBL] [Abstract][Full Text] [Related]
43. Intramyocardial and intracoronary basic fibroblast growth factor in porcine hibernating myocardium: a comparative study.
Biswas SS; Hughes GC; Scarborough JE; Domkowski PW; Diodato L; Smith ML; Landolfo C; Lowe JE; Annex BH; Landolfo KP
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):34-43. PubMed ID: 14752410
[TBL] [Abstract][Full Text] [Related]
44. Selective inhibition of the master regulator transcription factor Egr-1 with catalytic oligonucleotides reduces myocardial injury and improves left ventricular systolic function in a preclinical model of myocardial infarction.
Rayner BS; Figtree GA; Sabaretnam T; Shang P; Mazhar J; Weaver JC; Lay WN; Witting PK; Hunyor SN; Grieve SM; Khachigian LM; Bhindi R
J Am Heart Assoc; 2013 Jul; 2(4):e000023. PubMed ID: 23902638
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of percutaneous intramyocardial injections using a nonfluoroscopic 3-D mapping based catheter system.
Smits PC; van Langenhove G; Schaar M; Reijs A; Bakker WH; van der Giessen WJ; Verdouw PD; Krenning EP; Serruys PW
Cardiovasc Drugs Ther; 2002 Dec; 16(6):527-33. PubMed ID: 12766387
[TBL] [Abstract][Full Text] [Related]
46. Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.
Xiao B; Si X; Zhang M; Merlin D
Colloids Surf B Biointerfaces; 2015 Nov; 135():379-385. PubMed ID: 26275840
[TBL] [Abstract][Full Text] [Related]
47. Hexarelin targets neuroinflammatory pathways to preserve cardiac morphology and function in a mouse model of myocardial ischemia-reperfusion.
McDonald H; Peart J; Kurniawan ND; Galloway G; Royce SG; Samuel CS; Chen C
Biomed Pharmacother; 2020 Jul; 127():110165. PubMed ID: 32403043
[TBL] [Abstract][Full Text] [Related]
48. Biodegradable elastic patch plasty ameliorates left ventricular adverse remodeling after ischemia-reperfusion injury: a preclinical study of a porous polyurethane material in a porcine model.
Hashizume R; Fujimoto KL; Hong Y; Guan J; Toma C; Tobita K; Wagner WR
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):391-9.e1. PubMed ID: 23219497
[TBL] [Abstract][Full Text] [Related]
49. Positive effect of darbepoetin on peri-infarction remodeling in a porcine model of myocardial ischemia-reperfusion.
Toma C; Letts DP; Tanabe M; Gorcsan J; Counihan PJ
J Mol Cell Cardiol; 2007 Aug; 43(2):130-6. PubMed ID: 17597149
[TBL] [Abstract][Full Text] [Related]
50. Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
Santos-Gallego CG; Vahl TP; Goliasch G; Picatoste B; Arias T; Ishikawa K; Njerve IU; Sanz J; Narula J; Sengupta PP; Hajjar RJ; Fuster V; Badimon JJ
Circulation; 2016 Mar; 133(10):954-66. PubMed ID: 26826180
[TBL] [Abstract][Full Text] [Related]
51. Nanoparticle-Mediated Simultaneous Targeting of Mitochondrial Injury and Inflammation Attenuates Myocardial Ischemia-Reperfusion Injury.
Ikeda G; Matoba T; Ishikita A; Nagaoka K; Nakano K; Koga JI; Tsutsui H; Egashira K
J Am Heart Assoc; 2021 Jun; 10(12):e019521. PubMed ID: 34056918
[TBL] [Abstract][Full Text] [Related]
52. Intracoronary delivery of DNAzymes targeting human EGR-1 reduces infarct size following myocardial ischaemia reperfusion.
Bhindi R; Fahmy RG; McMahon AC; Khachigian LM; Lowe HC
J Pathol; 2012 Jun; 227(2):157-64. PubMed ID: 22344601
[TBL] [Abstract][Full Text] [Related]
53. Morphine post-conditioning-induced up-regulation of lncRNA TINCR protects cardiomyocytes from ischemia-reperfusion injury via inhibiting degradation and ubiquitination of FGF1.
Wang M; Liu S; Wang H; Tang R; Chen Z
QJM; 2020 Dec; 113(12):859-869. PubMed ID: 32176291
[TBL] [Abstract][Full Text] [Related]
54. Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response.
de Jong RCM; Pluijmert NJ; de Vries MR; Pettersson K; Atsma DE; Jukema JW; Quax PHA
Sci Rep; 2018 Apr; 8(1):6753. PubMed ID: 29712962
[TBL] [Abstract][Full Text] [Related]
55. Cortical bone stem cell-derived exosomes' therapeutic effect on myocardial ischemia-reperfusion and cardiac remodeling.
Schena GJ; Murray EK; Hildebrand AN; Headrick AL; Yang Y; Koch KA; Kubo H; Eaton D; Johnson J; Berretta R; Mohsin S; Kishore R; McKinsey TA; Elrod JW; Houser SR
Am J Physiol Heart Circ Physiol; 2021 Dec; 321(6):H1014-H1029. PubMed ID: 34623184
[TBL] [Abstract][Full Text] [Related]
56. Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury.
House SL; Castro AM; Lupu TS; Weinheimer C; Smith C; Kovacs A; Ornitz DM
Am J Physiol Heart Circ Physiol; 2016 Mar; 310(5):H559-71. PubMed ID: 26747503
[TBL] [Abstract][Full Text] [Related]
57. Attenuation of ischemia-reperfusion injury by intracoronary chelating agent administration.
Han D; Kang SH; Yoon CH; Youn TJ; Chae IH
Sci Rep; 2022 Feb; 12(1):2050. PubMed ID: 35136090
[TBL] [Abstract][Full Text] [Related]
58. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.
Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K
Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model.
Hinkel R; Penzkofer D; Zühlke S; Fischer A; Husada W; Xu QF; Baloch E; van Rooij E; Zeiher AM; Kupatt C; Dimmeler S
Circulation; 2013 Sep; 128(10):1066-75. PubMed ID: 23897866
[TBL] [Abstract][Full Text] [Related]
60. S-Nitrosoglutathione loaded poly(lactic-co-glycolic acid) microparticles for prolonged nitric oxide release and enhanced healing of methicillin-resistant Staphylococcus aureus-infected wounds.
Hlaing SP; Kim J; Lee J; Hasan N; Cao J; Naeem M; Lee EH; Shin JH; Jung Y; Lee BL; Jhun BH; Yoo JW
Eur J Pharm Biopharm; 2018 Nov; 132():94-102. PubMed ID: 30223029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
